Amicus Therapeutics, Inc. (FOLD)
14.24
-0.02
(-0.11%)
USD |
NASDAQ |
Dec 31, 16:00
14.21
-0.02
(-0.18%)
After-Hours: 17:54
Amicus Therapeutics Cash from Investing (Quarterly): -1.299M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -330.96M |
| CorMedix, Inc. | -291.32M |
| ANI Pharmaceuticals, Inc. | -6.163M |
| Gilead Sciences, Inc. | -427.00M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 35.66M |
| Cash from Financing (Quarterly) | -1.319M |
| Free Cash Flow | 9.691M |
| Free Cash Flow Per Share (Quarterly) | 0.1136 |
| Free Cash Flow to Equity (Quarterly) | 35.77M |
| Free Cash Flow to Firm (Quarterly) | 41.19M |
| Free Cash Flow Yield | 0.22% |